Rapafusyn Pharmaceuticals

📍 Baltimore, United States🗓 Founded 2015👥 9 employees💰 Last funded Mar 2021
Rapafusyn Pharmaceuticals is an emerging pharmaceutical development company located in Baltimore Maryland. Rapafusyn has licensed technology related to a novel class of natural product-like macrocycles from Johns Hopkins University School of Medicine and seeks to develop novel pharmaceuticals to treat patients having diseases and fulfill unmet medical needs.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Rapafusyn Pharmaceuticals?
Rapafusyn Pharmaceuticals has 1 investors on record on gritt.io and 1 late-stage investors.
When did Rapafusyn Pharmaceuticals last raise funding?
The most recent investment in Rapafusyn Pharmaceuticals recorded on gritt.io was in March 2021.
When was Rapafusyn Pharmaceuticals founded?
Rapafusyn Pharmaceuticals was founded in 2015.
What industry is Rapafusyn Pharmaceuticals in?
Rapafusyn Pharmaceuticals operates in Research Services. Find similar Research Services investors on gritt.io.
Where is Rapafusyn Pharmaceuticals based?
Rapafusyn Pharmaceuticals is headquartered in Baltimore, United States.